{"disease":{"id":"cmv-viremia","name":"cmv viremia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06263218","title":"Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Hospital do Rim e Hipertensão","has_results":false},{"nct_id":"NCT03443791","title":"Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT07079735","title":"Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT05432778","title":"Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT02136797","title":"Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT04298502","title":"The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04320303","title":"CMV Infection and Immune Intervention After Transplantation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04018261","title":"Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Banc de Sang i Teixits","has_results":false},{"nct_id":"NCT06011486","title":"Expansion of Virus-Specific Lymphocytes for Cell Therapy","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Hospital Israelita Albert Einstein","has_results":false},{"nct_id":"NCT03798301","title":"Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT03010332","title":"Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Atara Biotherapeutics","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}